nil
Conditions
Interventions
Ceftriaxone 1 g IV and Metronidazole 500 mg IV at induction of anaesthesia
Ceftriaxone Group Participants receive Ceftriaxone 1g IV at induction of anaesthesia.
Sponsors
AGBAGORO OGHENETEGA JESSE
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria for the study were women 1. Aged 15 to 49 years who were undergoing either elective or emergency caesarean sections 2. Who had a singleton pregnancy, 3. who do not have known allergies to Ceftriaxones or Metronidazole. 4. Booked patients
Exclusion criteria
Exclusion criteria: Exclusion criteria included women 1. with history of complications from previous caesarean sections, 2. those presenting with an active infection at the time of surgery, 3. individuals with known immunocompromised conditions such as HIV or undergoing chemotherapy, and those with pre-existing chronic conditions like diabetes or hypertension. 4. Also, patients having anaemia, BMI >30kg/m2, preoperative fever, antibiotics use within 1 week, allergic to ceftriaxone or metronidazole, 5.patients with ruptured membranes with evidence of infection and chorioamnionitis were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is the incidence of postoperative infections, such as surgical site infections and endometritis, within 30 days after surgery. Secondary outcomes include the length of hospital stay, incidence of adverse drug reactions, and the cost of treatment, both direct and indirect costs. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include the length of hospital stay, incidence of adverse drug reactions, and the cost of treatment, both direct and indirect costs. | — |
Countries
Nigeria
Contacts
Public ContactSAMUEL AIGERE
CONSULTANT OBGYN SPECIALIST
Outcome results
None listed